Rights and permissions
About this article
Cite this article
The androstene derivative L-39 shows antitumour activity against prostate cancer. Inpharma Wkly. 1245, 12 (2000). https://doi.org/10.2165/00128413-200012450-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012450-00025